Effects of prostate cancer screening on health-related quality of life: Results of the Finnish arm of the European randomized screening trial (ERSPC)
作者： Hanna Vasarainen , Hanna Malmi , Liisa Määttänen , Mirja Ruutu , Teuvo Tammela
DOI: 10.3109/0284186X.2013.802837
关键词:
摘要: AbstractBackground. As prostate cancer (PC) mortality reduction results are not unequivocal, a special emphasis has to be put on other aspects of the prostate-specific antigen (PSA) screening, including effects quality life. In present study we describe short-term various phases PC screening health-related life (HRQL). Material and methods. The participants were randomized into arm within Finnish component European Randomized Study Screening for Prostate Cancer (ERSPC). RAND 36-Item Health Survey HRQL questionnaires sociodemographic behavioral factors delivered at first round: 1) 500 invitation; 2) after screening; 3) obtaining PSA result; 4) 300 undergoing digital rectal examination (DRE) (but prior being informed its result); 5) approximately biopsy. At each stage, new samp...
informahealthcare.com参考文章(25)
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
Ruth E Collins, Laureen M Lopez, Theresa M Marteau, Emotional impact of screening: a systematic review and meta-analysis. BMC Public Health. ,vol. 11, pp. 603- 603 ,(2011) , 10.1186/1471-2458-11-603
Rhiannon C. Macefield, J. Athene Lane, Chris Metcalfe, Liz Down, David E. Neal, Freddie C. Hamdy, Jenny L. Donovan, Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy? European Journal of Cancer. ,vol. 45, pp. 2569- 2573 ,(2009) , 10.1016/J.EJCA.2009.03.016
FH Schröder, LJ Denis, M Roobol, None, The story of the European Randomized Study of Screening for Prostate Cancer BJUI. ,vol. 92, pp. 1- 13 ,(2003) , 10.1111/J.1464-410X.2003.04389.X
Ruth E Collins, Laureen M Lopez, Theresa M Marteau, Correction: Emotional impact of screening: A systematic review and meta-analysis BMC Public Health. ,vol. 11, pp. 752- 752 ,(2011) , 10.1186/1471-2458-11-752
M.L. Essink-Bot, I.J. Korfage, H.J. de Koning, Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited? BJUI. ,vol. 92, pp. 101- 105 ,(2003) , 10.1111/J.1464-410X.2003.04409.X
Meelan Bul, Fritz H. Schröder, Screening for prostate cancer – The controversy continues, but can it be resolved? Acta Oncologica. ,vol. 50, pp. 4- 11 ,(2011) , 10.3109/0284186X.2010.522197
N S Awsare, J S A Green, B Aldwinckle, D C Hanbury, G B Boustead, T A McNicholas, The measurement of psychological distress in men being investigated for the presence of prostate cancer Prostate Cancer and Prostatic Diseases. ,vol. 11, pp. 384- 389 ,(2008) , 10.1038/PCAN.2008.21
Floyd J. Fowler, Michael J. Barry, Beth Walker-Corkery, Jean-Francois Caubet, David W. Bates, Jeong Min Lee, Alison Hauser, Mary McNaughton-Collins, The impact of a suspicious prostate biopsy on patients’ psychological, socio-behavioral, and medical care outcomes Journal of General Internal Medicine. ,vol. 21, pp. 715- 721 ,(2006) , 10.1111/J.1525-1497.2006.00464.X
John E. Ware, Cathy Donald Sherbourne, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care. ,vol. 30, pp. 473- 483 ,(1992) , 10.1097/00005650-199206000-00002